BioCentury
ARTICLE | Top Story

Approvable letter for Lilly's Xigris

October 29, 2001 8:00 AM UTC

LLY received an approvable letter from the FDA for its Xigris drotrecogin alfa to treat sepsis with associated acute organ dysfunction. The approval is contingent upon labeling negotiations, including...